螺内酯改善心肌梗死患者左室重构的对照研究(2)
 |
| 第1页 |
参见附件。
因此，醛固酮拮抗劑联合血管紧张素受体拮抗剂全面阻断RAS系统对心血管系统的作用，抑制左室进一步扩大及纤维化，预防和改善心肌重构。
[参考文献]
[1] Perrier E，Kerfant BG，Lalevee N.Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction [J].Circulation，2004，110(7)：776-783.
[2] Silvestre JS，Robert V，Heymesc，et al.Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation[J].J Biol Chem， 1998(27)：4883-4891.
[3] Brilla MD，Zannad F，Remme WJ，et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure[J]. N Engl J Med，1999，341(10)：709-717.
[4] Weber K.Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure[J]. Am J Cardiol，1996，78(8)：902-907.
[5] Sharon AH.ACC/AHA guidelines for the evalution and management of Chronic Heart failure in the adult[J]. Am Coll Cardiol，2007，44(12)： 2101-2113.
[6] 冯惠清，崔炜，冯惠平，等.醛固酮对新生大鼠心肌成纤维细胞分泌ET、NO功能的影响[J].中国应用生理学杂志，2005(1)：78-80.
[7] Hafizi S， Wharton J，Chester AH，et al.Profibrotic effects of endothelin-1 via the ETA receptor in cultured humen cardiac fibroblasts[J].Cell Physiol Biochem，2004(14)： 285-292.
[8] Hayashi M， Tsutamoto，Wada A， et al.Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-in-farct left ventricular remodeling associated with suppression of a acute myocardial collagen synthesis in patients with first anterior acute myocardial infarction [J].Circulation， 2003，107(20)：2559-2565.
(收稿日期：2012-07-11)
您现在查看是摘要介绍页，详见PDF附件。